Sign in

NCT05465369CompletedPhase 3

Clinical Assessment of Injectable Flowable Composite with Giomer Technology Vs High Viscosity Glass Ionomer Restorations in ART for Cancer Patients

Clinical Assessment of Injectable Flowable Composite with Giomer Based Technology Versus High Viscosity Glass Ionomer Restorations in Atraumatic Restorative Treatment (ART) for Cancer Patients (One Year Randomized Clinical Trial)

Source: ClinicalTrials.gov · Last updated 25 Sept 2024

Brief summary (registry, in English)

Aim of the Study: This study will compare between injectable flowable composite (Beautifil flow plus x) and high viscosity glass ionomer (Equia Fil) by ART caries preventive protocol in high caries risk patients receiving chemotherapy and/or radiotherapy

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
190 (actual)
First submitted
15 Jul 2022
Start date
7 Feb 2023
Primary completion date
15 May 2024
Lead sponsor
Cairo University
NCT number
NCT05465369

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 190
  • From 7 Feb 2023 to the primary completion date, 15 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Patients whose systemic involvement was too advanced to allow dental manipulation, such as those who were admitted to the intensive care unit
  • Patients with parafunctional habits
  • Presence of any sign or symptoms of irreversible Pulpitis or necrotic pulp
  • Partially erupted teeth

Who the study is looking for

  • existing caries in permanent posterior teeth
  • Permanent posterior teeth with active carious lesion class I and class II without any signs and symptoms of pulp disease.
  • Teeth in normal occlusion
  • Absence of any active periodontal disease.

Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Children's Cancer Hospital Egypt 57357
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.